Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

591 ARTÍCULOS , VIENDO DEL 16 AL 30

CLARITY in Alzheimer's Research: Merging Tissue Transparency with Next-Gen Neurotechnologies

Trisal A, Singh AK.

J Neurosci Methods. 2025 Nov;423:110554. doi: 10.1016/j.jneumeth.2025.110554. Epub 2025 Aug 13.

Photothermal and Photodynamic Strategies for Diagnosis and Therapy of Alzheimer's Disease by Modulating Amyloid-β Aggregation

Gao F, Hou Y, Wang Y, Liu L, Yi X, Xia N.

Biosensors (Basel). 2025 Jul 24;15(8):480. doi: 10.3390/bios15080480.

Amyloid-related Imaging Abnormalities (ARIA) in the Context of Alzheimer's Disease and Amyloid-targeting Therapies: An Introduction for Advanced Practice Providers

Schreiber CP, Kovacik A, Bishop J, Helman J.

Drugs Aging. 2025 Dec;42(12):1103-1111. doi: 10.1007/s40266-025-01253-x. Epub 2025 Oct 3.

Breaking the Alzheimer's Treatment Stalemate: Synergistic Application Strategies of Nanomaterials and Pharmaceutical Agents

Gao H, Cheng F, Zhang Z, Yan B, Liao P, Zhang S, Li D, Chen F, Lei P.

Mol Neurobiol. 2025 Nov 20;63(1):107. doi: 10.1007/s12035-025-05320-7.

Therapeutic and Diagnostic Roles of MSC-Derived Exosomes in Alzheimer's Disease

Patil VS, Parekh B, Sharma A, Farah H, Jyothi-S R, Mishra S, Nanda A, Al-Hasnaawei S, Kumar-Mishra M.

Brain Behav. 2025 Dec;15(12):e71112. doi: 10.1002/brb3.71112.

Non-Invasive Techniques for Early Alzheimer's Disease Detection: A Survey

Franco A, Zayene MA, Basly H, Sayadi FE.

Stud Health Technol Inform. 2025 Oct 3;330:695-713. doi: 10.3233/SHTI251458.

Monoamine alterations in Alzheimer's disease and their implications in comorbid neuropsychiatric symptoms

Saggu S, Bai A, Aida M, Rehman H, Pless A, Ware D, Deak F, Jiao K, Wang Q.

Geroscience. 2025 Feb;47(1):457-482. doi: 10.1007/s11357-024-01359-x. Epub 2024 Sep 27.

Neuropathology meets chemical and genetic pathology head-on: a personal perspective

Masters CL.

Pathology. 2025 Mar;57(2):191-195. doi: 10.1016/j.pathol.2024.11.001. Epub 2024 Nov 20.

A Multiform Heterogeneity Framework for Alzheimer's Disease Based on Multimodal Neuroimaging

Zhao K, Chen P, Wang D, Zhou R, Ma G, Liu Y.

Biol Psychiatry. 2025 Jun 1;97(11):1022-1033. doi: 10.1016/j.biopsych.2024.12.009. Epub 2024 Dec 24.

Traversing Shifting Sands-the Challenges of Caring for Someone With Alzheimer's Disease and the Impact on Care Partners: Social Media Content Analysis

Frederiksen KS, Hahn-Pedersen J, Crawford R, Morrison R, Jeppesen R, Doward L, Weidner W.

J Med Internet Res. 2025 Feb 18;27:e55468. doi: 10.2196/55468.

Utilization of precision medicine digital twins for drug discovery in Alzheimer's disease

Ren Y, Pieper AA, Cheng F.

Neurotherapeutics. 2025 Apr;22(3):e00553. doi: 10.1016/j.neurot.2025.e00553. Epub 2025 Feb 17.

Exploring Alzheimer's disease treatment: Established therapies and novel strategies for future care

Soni U, Singh K, Jain D, Pujari R.

Eur J Pharmacol. 2025 Jul 5;998:177520. doi: 10.1016/j.ejphar.2025.177520. Epub 2025 Mar 15.

Improving executive functioning and reducing the risk of Alzheimer's disease with music therapy: A narrative review of potential neural mechanisms

Slade B, Williams B, Engelbrecht R, Ciorciari J.

J Alzheimers Dis. 2025 May;105(2):319-330. doi: 10.1177/13872877251327762. Epub 2025 Mar 24.

Advances in diagnostic imaging of the glial lymphatic system in Alzheimer's Disease

Mi F, Yang X, Huang X, Xu G, Pan D, Yu C.

Brain Res Bull. 2025 Jul;227:111377. doi: 10.1016/j.brainresbull.2025.111377. Epub 2025 May 9.

MRI protocols and sequences for amyloid-related imaging abnormalities monitoring in Alzheimer's disease patients treated with monoclonal antibodies

Agosta F, Cecchetti G, Spinelli EG, Ghirelli A, Rugarli G, Filippi M.

Curr Opin Neurol. 2025 Aug 1;38(4):289-297. doi: 10.1097/WCO.0000000000001388. Epub 2025 Jun 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias